Mandate

Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se

March 15, 2022 M&A

InnovDr is a digital provider of health and medical services. The business, which started in 2016, consists of Kollarna.se and the subareas urinkollen.se, aknekollen.se, borreliakollen.se, menskollen.se, ögonkollen.se and herpeskollen.se.

The owners of InnovDr divest the company to Doktor.se, which is one of the leading companies in digital care in Sweden.

Vinge’s team consisted of Wibeke Sorling, Jenny Sandlund, Hanna Jansson and Amanda Stoltz.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024